Skip to content
drillr.ai
Sign up

603233.SH

DaShenLin Pharmaceutical Group Co., Ltd.

SSE · Healthcare · Biotechnology · CN

CNY 18.29
−1.03%
Ask drillr

  • Oct 29, 2026, 09:09 UTC

    Dashenlin reported first-nine-month 2026 revenue of CNY 21.308 billion, net profit of CNY 1.271 billion and adjusted net profit of CNY 1.272 billion.

    Source:

  • Oct 29, 2026, 09:09 UTC

    Dashenlin reported third-quarter 2026 revenue of CNY 7.317 billion, net profit of CNY 344 million and adjusted net profit of CNY 341 million.

    Source:

  • Oct 13, 2026, 09:22 UTC

    Dachenglin announced that its Dacheng Convertible Bonds will mature and be redeemed for 110 yuan per bond, including tax, with payment on October 22, 2026, and delisting that day.

    Source:

  • Aug 24, 2026, 09:31 UTC

    Dashenlin's board proposed a cash dividend of 0.41 yuan per share (including tax) for the first half of 2026.

    Source:

  • Aug 24, 2026, 09:31 UTC

    Dashenlin announced its first-half 2026 results: revenue of 13.991 billion yuan, up 3.46% year-on-year; net profit attributable to shareholders of 927 million yuan, up 16.10% year-on-year.

    Source: